Neuroprotective effects of inhibitors of dipeptidyl peptidase-IV in vitro and in vivo

Advances in Experimental Medicine and Biology

Volumn 524, Issue , 2003, Pages 351-355

  Wu, Yong Qian ^a   Limburg, David C ^a   Wilkinson, Douglas E ^a   Jackson, Paul ^a   Steiner, Joseph P ^a   Hamilton, Gregory S ^a   Belyakov, Sergei A ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIGENS, CD26; CELL DEATH; MICE; MOTOR NEURONS; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; PROTEASE INHIBITORS;

EID: 0038025675     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (7)

1. Hildebrandt, M., Reutter, W., Arck, P., Rose, M., and Klapp, B.F. A Guardian Angel: The Involvement of Dipeptidyl Peptidase IV In Psychoneuroendocrine Function, Nutrition, and Immune Defence. 2000, Clinical Sci, 99: 93-104.
2. Medeiros, M.S., and Turner, A.J. Processing And Metabolism of Peptide YY. 1993, Biochem. Soc. Trans. 21: 248S; Kato, T., Nagatsu, T., Fukazawa, K., Harada, M., Nagatsu, I., and Sakakibura, S. Successive Cleavage of N-Terminal Arg-Pro and Lys-Pro From Substance P But No Release of Arg-Pro From Bradykinin, By X-Pro Dipeptidyl-Aminopeptidase. 1978, Biochim. Biophys, Acta 525: 417-422.
3. Medeiros, M.S., and Turner, A.J. Processing And Metabolism of Peptide YY. 1993, Biochem. Soc. Trans. 21: 248S; Kato, T., Nagatsu, T., Fukazawa, K., Harada, M., Nagatsu, I., and Sakakibura, S. Successive Cleavage of N-Terminal Arg-Pro and Lys-Pro From Substance P But No Release of Arg-Pro From Bradykinin, By X-Pro Dipeptidyl-Aminopeptidase. 1978, Biochim. Biophys, Acta 525: 417-422.
4. 1 in PWM-stimulated PBMC and T-cells. 1997, Immunology 91: 354-360
5. Hughes, T.E., Mone, M.D., Russell, M.E., Weldon, S.C., and Villhauer, E.B. (1-[[[2-[(5-Cyanopyrrolidin-2-yl)amino]ethyl]amino] acetyl]-2-cyano-(S)-pyrrolidine, a Slow-Binding Inhibitor of Dipeptidyl Peptidase IV. 1999, Biochemistry 38: 11597-11603.
6. Rothstein, J.D., Jin, L., Dykes-Hoberg, M. and Kuncl, R. W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. 1993, Proc. Natl. Acad. Sci. USA 90: 6591-6595.
7. Steiner J.P., Hamilton G.S., Ross D.T., Valentine H.L., Guo H., Connolly M.A., Liang S., Ramsey C., Li J.H., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A.C., and Suzdak P.D. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. 1997, Proc Natl. Acad. Sci. USA 94: 2019-2024.